The NIH BD2K Center of Excellence in Biomedical Computing,
Department of Medicine/Cardiology
Karol Watson has not added Biography.
If you are Karol Watson and would like to personalize this page please email our Author Liaison for assistance.
Lipid lowering in high-risk populations: how low should we go?
Ethnicity & disease , 2001 | Pubmed ID: 11763308
Therapeutic lifestyle changes for hypertension and cardiovascular risk reduction.
Journal of clinical hypertension (Greenwich, Conn.) Jan-Feb, 2003 | Pubmed ID: 12556671
Plasma lipoprotein concentrations in ethnic populations.
Current cardiology reports Nov, 2003 | Pubmed ID: 14558991
Lessons learned from recent lipid-lowering trials: why physicians should change clinical practice.
Clinical cornerstone , 2003 | Pubmed ID: 14699987
Atherosclerosis in type 2 diabetes mellitus: the role of insulin resistance.
Journal of cardiovascular pharmacology and therapeutics Dec, 2003 | Pubmed ID: 14740074
Surgical risk in patients with metabolic syndrome: focus on lipids and hypertension.
Current cardiology reports Nov, 2006 | Pubmed ID: 17059795
Managing cardiometabolic risk: an evolving approach to patient care.
Critical pathways in cardiology Mar, 2007 | Pubmed ID: 17667880
Quality indicators for the care of ischemic heart disease in vulnerable elders.
Journal of the American Geriatrics Society Oct, 2007 | Pubmed ID: 17910559
Cardiovascular risk reduction among African Americans: a call to action.
Journal of the National Medical Association Jan, 2008 | Pubmed ID: 18277804
What is the evidence in favor of low-dose statin therapy in 2008?
Current atherosclerosis reports Feb, 2008 | Pubmed ID: 18366983
Acculturation is associated with left ventricular mass in a multiethnic sample: the Multi-Ethnic Study of Atherosclerosis.
BMC cardiovascular disorders Dec, 2015 | Pubmed ID: 26631068
The 2013 ACC/AHA Cholesterol Treatment Guidelines: Applicability to Patients with Diabetes.
Current diabetes reports Feb, 2016 | Pubmed ID: 26803649
Slippery Slope of Triglycerides: They Are Associated With Risk, But in the Statin Era, Does Targeting Them Confer Benefit?
Circulation. Cardiovascular quality and outcomes Mar, 2016 | Pubmed ID: 26957516
MY APPROACH to the Patient With Memory Loss Who Needs a Statin.
Trends in cardiovascular medicine 02, 2017 | Pubmed ID: 28107839
Neighborhoods and racial/ethnic differences in ideal cardiovascular health (the Multi-Ethnic Study of Atherosclerosis).
Health & place Mar, 2017 | Pubmed ID: 28167269
Triglycerides: A reappraisal.
Trends in cardiovascular medicine 08, 2017 | Pubmed ID: 28438398
Closing the Remaining Evidence Gap: Randomized Controlled Trial Data to Support Statin Therapy for Low-Density Lipoprotein ≥190 mg/dL.
Circulation Nov, 2017 | Pubmed ID: 29133529
John Harry Caufield1,2,
David A. Liem1,2,3,
Anders O. Garlid1,2,
Yijiang Zhou4,
Karol Watson1,3,
Alex A. T. Bui1,5,6,7,
Wei Wang1,7,8,9,
Peipei Ping1,2,3,7,8
1The NIH BD2K Center of Excellence in Biomedical Computing, University of California, Los Angeles,
2Department of Physiology, University of California, Los Angeles,
3Department of Medicine/Cardiology, University of California, Los Angeles,
4Department of Cardiology, First Affiliated Hospital, Zhejiang University School of Medicine,
5Department of Radiological Sciences, University of California, Los Angeles,
6Department of Bioengineering, University of California, Los Angeles,
7Scalable Analytics Institute (ScAi), University of California, Los Angeles,
8Department of Bioinformatics, University of California, Los Angeles,
9Department of Computer Science, University of California, Los Angeles
关于 JoVE
版权所属 © 2024 MyJoVE 公司版权所有,本公司不涉及任何医疗业务和医疗服务。